Metronidazole - Galderma

Drug Profile

Metronidazole - Galderma

Alternative Names: GSK 567; Metrogel; Rozex

Latest Information Update: 04 Aug 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dow Pharmaceutical Sciences
  • Developer Dow Pharmaceutical Sciences; Galderma
  • Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Small molecules
  • Mechanism of Action DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Rosacea; Skin ulcer

Most Recent Events

  • 20 Jul 2016 Galderma enters into an agreement with Maruho to acquire metronidazole gel in Japan (Rozex)
  • 15 Mar 2016 Biomarkers information updated
  • 27 Oct 2015 Launched for Skin ulcer in Japan (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top